What's happening
Reference profile
Generated 18:15 ET
IMNN — Imunon, Inc. Common Stock is down 2.4%, at 1.63, on $245.9K traded, 0.06× float rotation. Score 36. Primary driver: 6.5% float rotation.
Get alerts on $IMNN
Halts, resumptions, new filings, and updated reports — in your inbox within minutes of the event.
Free · one email per event, no digests or spam · unsubscribe anytime · joins real followers
Free float
2.3M
2026-03-30
Shares out
4.2M
latest detail
Market cap
$7.0M
at ref price
Short interest
2.2%
2026-06-30
Float rotation
0.06×
latest snapshot
20d dollar vol
$413.6K
baseline
Gap quality
unscored
live supply-pressure model
This estimates whether a gap is clean, squeeze-prone, mixed, or supply-heavy using float, float rotation, short interest, market cap, split risk, and live volume. Registered resale/ATM exhaustion is a planned deeper parser layer.
2026-07-22 14:55 ETSignalImunon, Inc. Common Stock is down 2.4%, at 1.63, on $245.9K traded, 0.06× float rotation. Score 36. Primary driver: 6.5% float rotation.
2026-06-308-KItem 5.02 — Director or officer departure/election/appointment; Item 9.01 — Financial statements and exhibits SEC
2026-06-168-KItem 5.02 — Director or officer departure/election/appointment; Item 9.01 — Financial statements and exhibits SEC
2026-06-048-KItem 1.01 — Entry into a material definitive agreement; Item 2.03 — Creation of a direct financial obligation +1 more SEC
2026-05-128-KItem 2.02 — Results of operations and financial condition; Item 9.01 — Financial statements and exhibits SEC
2026-05-048-KItem 5.02 — Director or officer departure/election/appointment; Item 9.01 — Financial statements and exhibits SEC
2026-03-24 08:00 ETFDA / ClinicalIMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026 News
2025-08-07Split1.15 split ratio logged
2025-08-05 16:00 ETFDA / ClinicalIMUNON Recaps Highlights from 2025 Second Quarter Financial Results Conference Call News
2025-05-23 18:59 ETOfferingIMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules News
2024-06-24 08:30 ETFDA / ClinicalIMUNON Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer News
Latest detector signalscore 36